News
Globus Medical CEO Daniel Scavilla’s salary rose to $4.8 million in 2024, according to the company’s April 25 Securities and Exchange Commission proxy filing. Compensation packages for executives ...
StockStory.org on MSN8d
Globus Medical (GMED): Buy, Sell, or Hold Post Q4 Earnings?Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...
The annual event for Children's Therapy Center of the Quad Cities will be held at Mississippi Valley Fairgrounds on April 19. Doors open at 11 a.m. It's free, but a suggested donation of $5 ...
Sean Barbabella. The White House released Trump's three-page medical report Sunday morning following the president's annual physical examination at Walter Reed National Military Medical Center on ...
Judge Jason Scott issued the ruling broadening the medical exception to the ban, allowing doctors to perform an abortion if “good faith medical judgment” shows a patient with an existing ...
Getting life insurance typically requires a medical exam to give your provider a clearer picture of your health status. But there are policies available that don't require an examination ...
Globus Medical GMED has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...
Truist lowered the firm’s price target on Globus Medical (GMED) to $80 from $82 and keeps a Hold rating on the shares as part of a broad research note previewing Q1 results in Medical Technology.
On Thursday, JMP analysts maintained their Market Perform rating for Globus Medical (NYSE:GMED) stock, currently trading at $74.28 with a market capitalization of $10.22 billion. The analysts' stance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results